Does complete pathological response increase perioperative morbidity risk in rectal cancer?
- 11 March 2024
- journal article
- research article
- Published by Wiley in Colorectal Disease
- Vol. 26 (5) , 916-925
Abstract
Aim The optimal management of patients with clinical complete response after neoadjuvant treatment for rectal cancer is controversial. The aim of this study is to compare the morbidity between patients with locally advanced rectal cancer who have had a pathological complete response (pCR) or not after neoadjuvant chemoradiotherapy (NCRT) and total mesorectal excision (TME). The study hypothesis was that pCR may impact the surgical complication rate. Method A retrospective cohort study was conducted of a prospectively maintained database in Australia and New Zealand, the Binational Colorectal Cancer Audit, that identified patients with locally advanced rectal cancer (= 3 (p < 0.0002) did. In addition, pCR had no significant effect (p = 0.44) but male gender (p = 0.0047) and interval to surgery (p = 0.015) contributed to higher rates of anastomotic leak. In the TME without anastomosis cohort, the only variable that contributed to higher rates of complications was ASA score >= 3 (p = 0.033). Conclusion Patients undergoing TME dissection for rectal cancer following NCRT showed no difference in complications whether they had achieved pCR or not.Keywords
This publication has 12 references indexed in Scilit:
- Ten‐year survival after pathologic complete response in rectal adenocarcinomaJournal of Surgical Oncology, 2020
- Is watch and wait a safe and effective way to treat rectal cancer in older patients?European Journal of Surgical Oncology, 2020
- Population-based study of morbidity risk associated with pathological complete response after chemoradiotherapy for rectal cancerBritish Journal of Surgery, 2019
- Achieving a Complete Clinical Response After Neoadjuvant Chemoradiation That Does Not Require Surgical Resection: It May Take Longer Than You Think!Diseases of the Colon & Rectum, 2019
- Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant TherapyJAMA Oncology, 2019
- Effect of increasing radiation dose on pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation therapyActa Oncologica, 2016
- Impact of Organ-Preserving Strategies on Anorectal Function in Patients with Distal Rectal Cancer Following Neoadjuvant ChemoradiationDiseases of the Colon & Rectum, 2016
- Assessing pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic reviewColorectal Disease, 2015
- Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation TherapyAnnals of Surgery, 2004
- Low rectal cancerDiseases of the Colon & Rectum, 1998